Insights
Median is a disrupter in the area of medical imaging analysis. Find out more about what we are doing and how our technology works.
Conferences
Sept 6-9, 2025World Conference on Lung Cancer (WCLC) 2025
Join us at the World Conference on Lung Cancer (WCLC) in Barcelona, Spain from September 6-9, 2025. Visit us at Booth #420 to discover the latest advancements in eyonis® LCS: our AI/ML technology-based Software as a Medical Device designed to support radiologists and pulmonologists in lung cancer screening.
Webinars
Closing the Gap: Strategies for Resolving Imaging Discrepancies in Oncology Drug Trials
Articles
-
[Podcast] – Shaping Results through Imaging: Addressing Variability in Oncology Trials
This is an excerpt from our podcast “Shaping Results through Imaging: Addressing Variability in Oncology Trials”. Listen to full version of the podcast here : Connor Anderson – Project Manager II, Median Technologies: Thank you for joining this podcast. We are going to start the interview by setting the stage. Can you describe the role imaging…
Brochures
eyonis™
End-to-end AI/ML tech-based CADe/CADx SaMD
Scientific publications
AI-assisted Lung Cancer Screening: Results from REALITY, a pivotal validation study of an AI/ML-based software
Presented at the American Thoracic Society Congress in San Francisco
Case studies
Accelerating Site Startups Across the Globe for Oncology Clinical Trial Imaging
White papers
Patient’s Body Composition in Oncology Trials: A Case for Implementation
Developed in collaboration with Syneos Health, this white paper explores the barriers preventing its widespread adoption, including challenges related to clinical evidence, accessibility of assessment tools, usability, and cost-effectiveness.